The commitment to the Zeiss Convivo brand is there, importantly, it will be a critical part of a suite of "advanced surgical certainty" products. CZM is not a company that sets out its wares, with high production value videos, with a view to failure.
The cheapest and easiest way forward for CZM will be to buy Optiscan and the associated IP. Wishful thinking? Time will tell.
"Optiscan’s optical fibre confocal microscope patents will expire in July and August 2009, while the patents over the miniaturised scanning systems provide for significant extended protection through to 2019".
The commitment to the Zeiss Convivo brand is there, importantly,...
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add OIL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
18.0¢ |
Change
0.010(5.88%) |
Mkt cap ! $150.3M | |||
| Open | High | Low | Value | Volume |
| 17.0¢ | 18.0¢ | 16.5¢ | $10.39K | 59.96K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 245 | 17.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 18.0¢ | 16576 | 1 |
View Market Depth
| Last trade - 15.44pm 04/09/2024 (20 minute delay) ? |
| OIL (ASX) Chart |